换一批TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
第一作者：
L F,Lincz
第一单位：
Hunter Haematology Research Group, Mater Misericordiae Hospital, NSW, Australia.
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);凋亡调节蛋白质类(Apoptosis Regulatory Proteins);骨髓细胞(Bone Marrow Cells);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性(Drug Resistance);流式细胞术(Flow Cytometry);GPI连接蛋白质类(GPI-Linked Proteins);人类(Humans);白细胞, 单核(Leukocytes, Mononuclear);膜糖蛋白类(Membrane Glycoproteins);多发性骨髓瘤(Multiple Myeloma);RNA, 信使(RNA, Messenger);受体, TNF相关凋亡诱导配体(Receptors, TNF-Related Apoptosis-Inducing Ligand);受体, 肿瘤坏死因子(Receptors, Tumor Necrosis Factor);受体, 肿瘤坏死因子, 成员10c(Receptors, Tumor Necrosis Factor, Member 10c);TNF相关凋亡诱导配体(TNF-Related Apoptosis-Inducing Ligand);肿瘤细胞, 培养的(Tumor Cells, Cultured);肿瘤坏死因子诱骗受体(Tumor Necrosis Factor Decoy Receptors);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.1038/sj.leu.2402251
PMID
11587225
发布时间
2019-09-15
- 浏览24
Leukemia
1650-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
